Senior insider sale
SVP, Comm & Medical Affairs at THERAVANCE BIOPHARMA, INC. — senior position signals high conviction
$413.9K
38K shares
FARNUM RHONDA plans to sell 38K shares of THERAVANCE BIOPHARMA, INC. valued at approximately $413.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock
Not Applicable
Restricted Stock
Not Applicable
Restricted Stock
Not Applicable
Employee Stock Purchase Plan
Cash
Restricted Stock
Not Applicable
Performance Shares
Not Applicable
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/20/2021 | Restricted Stock Not Applicable | 2.59K | — |
5/20/2021 | Restricted Stock Not Applicable | 1.80K | — |
11/20/2020 | Restricted Stock Not Applicable | 635.00 | — |
11/13/2020 | Employee Stock Purchase Plan Cash | 682.00 | — |
8/20/2020 | Restricted Stock Not Applicable | 301.00 | — |
2/20/2020 | Performance Shares Not Applicable | 4K | — |
| Total | 10K | ||
Completed
Units to sell
7.12K
Market value
$78.4K
Units to sell
2.82K
Market value
$31.0K
Units to sell
561.00
Market value
$6.2K
Units to sell
13.50K
Market value
$148.5K
Units to sell
4K
Market value
$36.0K
Planned — Approximate Date
Units to sell
10K
Market value
$113.9K
Units
38K
Value
$413.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/2/2025 | 7.12K | $78.4K | — | Completed |
6/2/2025 | 2.82K | $31.0K | — | Completed |
6/2/2025 | 561.00 | $6.2K | — | Completed |
6/2/2025 | 13.50K | $148.5K | — | Completed |
4/21/2025 | 4K | $36.0K | — | Completed |
| Planned — Approximate Date | ||||
7/14/2025 | 10K | $113.9K | NASDAQ | Planned |
| Total | 38K | $413.9K | ||